Palonosetron-Teva 0.25 mg/5 ml, Injektionslösung

7680686710016 CH-68671 Injektionslösung
Palonosetron-Teva 0.25 mg/5 ml, Injektionslösung
Palonosetron-Teva 0.25 mg/5 ml, Injektionslösung
Palonosetron-Teva 0.25 mg/5 ml, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/01/2023
Summary of Product Characteristics
Français
17/01/2023
Summary of Product Characteristics
Italien
17/01/2023

Detailed composition

Substance Quantity Type Category
(N/A)
0.25 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 60.75
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/10/2022

Authorization holder

Teva Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
68671
Drug name
Palonosetron-Teva, Injektionslösung
Galenic form
LSINJ
ATC Code
A04AA05
Authorization status
Z
Dispensing category
B
First authorization
08/07/2022
Authorization expiration date
07/07/2027
IT Number
01.09.0.
Domain
Human medicine
Field of application
Antiemetikum

Package details

Description (FR)
PALONOSETRON Teva sol inj 0.25 mg/5ml flac
Description (DE)
PALONOSETRON Teva Inj Lös 0.25 mg/5ml Durchstf
Market launch
08/07/2022
Narcotic (BTM)
No

Original drug

Aloxi, Injektionslösung
GTIN: 7680570420014
CHF 68.15
View original